Structure

Physi-Chem Properties

Molecular Weight:  584.23
Volume:  574.914
LogP:  1.952
LogD:  2.344
LogS:  -4.457
# Rotatable Bonds:  11
TPSA:  145.53
# H-Bond Aceptor:  11
# H-Bond Donor:  4
# Rings:  5
# Heavy Atoms:  11

MedChem Properties

QED Drug-Likeness Score:  0.262
Synthetic Accessibility Score:  4.362
Fsp3:  0.419
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  1
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.661
MDCK Permeability:  2.242881055281032e-05
Pgp-inhibitor:  0.725
Pgp-substrate:  0.622
Human Intestinal Absorption (HIA):  0.027
20% Bioavailability (F20%):  0.002
30% Bioavailability (F30%):  0.014

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.081
Plasma Protein Binding (PPB):  75.5647201538086%
Volume Distribution (VD):  0.504
Pgp-substrate:  18.535415649414062%

ADMET: Metabolism

CYP1A2-inhibitor:  0.013
CYP1A2-substrate:  0.538
CYP2C19-inhibitor:  0.035
CYP2C19-substrate:  0.773
CYP2C9-inhibitor:  0.345
CYP2C9-substrate:  0.774
CYP2D6-inhibitor:  0.106
CYP2D6-substrate:  0.493
CYP3A4-inhibitor:  0.494
CYP3A4-substrate:  0.77

ADMET: Excretion

Clearance (CL):  6.082
Half-life (T1/2):  0.645

ADMET: Toxicity

hERG Blockers:  0.349
Human Hepatotoxicity (H-HT):  0.127
Drug-inuced Liver Injury (DILI):  0.672
AMES Toxicity:  0.102
Rat Oral Acute Toxicity:  0.039
Maximum Recommended Daily Dose:  0.17
Skin Sensitization:  0.878
Carcinogencity:  0.09
Eye Corrosion:  0.003
Eye Irritation:  0.027
Respiratory Toxicity:  0.051

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC114119

Natural Product ID:  NPC114119
Common Name*:   Ficusesquilignan A
IUPAC Name:   (1R,2S)-2-[4-[(3R,3aS,6R,6aS)-6-(4-hydroxy-3,5-dimethoxyphenyl)-1,3,3a,4,6,6a-hexahydrofuro[3,4-c]furan-3-yl]-2-methoxyphenoxy]-1-(4-hydroxy-3-methoxyphenyl)propane-1,3-diol
Synonyms:   Ficusesquilignan A
Standard InCHIKey:  PFZFCRCFYYFTPE-RWMYVIIASA-N
Standard InCHI:  InChI=1S/C31H36O11/c1-36-23-9-16(5-7-21(23)33)28(34)27(13-32)42-22-8-6-17(10-24(22)37-2)30-19-14-41-31(20(19)15-40-30)18-11-25(38-3)29(35)26(12-18)39-4/h5-12,19-20,27-28,30-35H,13-15H2,1-4H3/t19-,20-,27+,28-,30+,31+/m1/s1
SMILES:  COc1cc(ccc1O)[C@H]([C@H](CO)Oc1ccc(cc1OC)[C@H]1[C@@H]2CO[C@@H](c3cc(c(c(c3)OC)O)OC)[C@@H]2CO1)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL1760589
PubChem CID:   54580061
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0001392] Lignans, neolignans and related compounds
      • [CHEMONTID:0003686] Furanoid lignans

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO4001 Berberis koreana Species Berberidaceae Eukaryota n.a. n.a. n.a. PMID[19813743]
NPO4001 Berberis koreana Species Berberidaceae Eukaryota trunk Jeju island, Korea 2005-Dec PMID[21420296]
NPO4001 Berberis koreana Species Berberidaceae Eukaryota n.a. n.a. n.a. PMID[21420296]
NPO4001 Berberis koreana Species Berberidaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT34 Cell Line BV-2 Mus musculus IC50 > 500000.0 nM PMID[490713]
NPT81 Cell Line A549 Homo sapiens IC50 > 30000.0 nM PMID[490713]
NPT147 Cell Line SK-MEL-2 Homo sapiens IC50 = 11520.0 nM PMID[490713]
NPT574 Cell Line XF498 Homo sapiens IC50 = 9470.0 nM PMID[490713]
NPT146 Cell Line SK-OV-3 Homo sapiens IC50 > 30000.0 nM PMID[490713]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC114119 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC471415
1.0 High Similarity NPC470097
0.9855 High Similarity NPC324492
0.9855 High Similarity NPC317053
0.9784 High Similarity NPC320671
0.9784 High Similarity NPC327412
0.9784 High Similarity NPC328567
0.9784 High Similarity NPC320970
0.9706 High Similarity NPC291101
0.9706 High Similarity NPC266197
0.9645 High Similarity NPC473266
0.9645 High Similarity NPC470098
0.9645 High Similarity NPC470826
0.9571 High Similarity NPC260397
0.951 High Similarity NPC324517
0.951 High Similarity NPC321972
0.951 High Similarity NPC329343
0.9489 High Similarity NPC22517
0.9485 High Similarity NPC77861
0.942 High Similarity NPC55793
0.9412 High Similarity NPC141765
0.9412 High Similarity NPC99572
0.9412 High Similarity NPC165155
0.9412 High Similarity NPC24490
0.9412 High Similarity NPC126409
0.9412 High Similarity NPC34103
0.9371 High Similarity NPC51328
0.9371 High Similarity NPC286235
0.9371 High Similarity NPC55158
0.9362 High Similarity NPC181615
0.9338 High Similarity NPC244983
0.9338 High Similarity NPC287745
0.9338 High Similarity NPC326095
0.9301 High Similarity NPC248132
0.9301 High Similarity NPC130449
0.9281 High Similarity NPC184797
0.9281 High Similarity NPC309124
0.927 High Similarity NPC93783
0.9265 High Similarity NPC158331
0.9231 High Similarity NPC39657
0.9214 High Similarity NPC263261
0.9214 High Similarity NPC311530
0.9214 High Similarity NPC178054
0.9214 High Similarity NPC470372
0.9214 High Similarity NPC87725
0.9209 High Similarity NPC236306
0.9209 High Similarity NPC473739
0.9209 High Similarity NPC232164
0.9197 High Similarity NPC170694
0.9191 High Similarity NPC470752
0.9191 High Similarity NPC160991
0.9191 High Similarity NPC184447
0.9191 High Similarity NPC16208
0.9191 High Similarity NPC7903
0.9191 High Similarity NPC175067
0.9191 High Similarity NPC204215
0.9191 High Similarity NPC35932
0.9149 High Similarity NPC302506
0.9149 High Similarity NPC107161
0.9143 High Similarity NPC254759
0.9143 High Similarity NPC160283
0.9137 High Similarity NPC474390
0.9118 High Similarity NPC158079
0.9118 High Similarity NPC470095
0.9118 High Similarity NPC469625
0.9118 High Similarity NPC309787
0.9118 High Similarity NPC7171
0.9118 High Similarity NPC40432
0.9118 High Similarity NPC470096
0.9118 High Similarity NPC472597
0.9118 High Similarity NPC469613
0.9118 High Similarity NPC161557
0.9118 High Similarity NPC228346
0.9118 High Similarity NPC30043
0.9118 High Similarity NPC474017
0.9118 High Similarity NPC115207
0.9118 High Similarity NPC27843
0.9116 High Similarity NPC470769
0.9091 High Similarity NPC279298
0.9091 High Similarity NPC22150
0.9091 High Similarity NPC38041
0.9085 High Similarity NPC477616
0.9078 High Similarity NPC471389
0.9078 High Similarity NPC247291
0.9071 High Similarity NPC292882
0.9071 High Similarity NPC260842
0.9065 High Similarity NPC265433
0.9065 High Similarity NPC306441
0.9065 High Similarity NPC16435
0.9065 High Similarity NPC270456
0.9065 High Similarity NPC162659
0.9065 High Similarity NPC248727
0.9058 High Similarity NPC310854
0.9054 High Similarity NPC157333
0.9051 High Similarity NPC201587
0.9051 High Similarity NPC181049
0.9051 High Similarity NPC253105
0.9051 High Similarity NPC207400
0.9051 High Similarity NPC4940
0.9044 High Similarity NPC174495
0.9044 High Similarity NPC242807
0.9044 High Similarity NPC469612
0.9044 High Similarity NPC153739
0.9044 High Similarity NPC469614
0.9044 High Similarity NPC145305
0.9044 High Similarity NPC241522
0.9044 High Similarity NPC472338
0.9044 High Similarity NPC42300
0.9044 High Similarity NPC92164
0.9044 High Similarity NPC257582
0.9044 High Similarity NPC77040
0.9044 High Similarity NPC64201
0.9044 High Similarity NPC187998
0.9041 High Similarity NPC477612
0.9034 High Similarity NPC102934
0.9034 High Similarity NPC226153
0.9034 High Similarity NPC304048
0.9034 High Similarity NPC252402
0.9034 High Similarity NPC20757
0.9034 High Similarity NPC329836
0.9034 High Similarity NPC227516
0.9028 High Similarity NPC112861
0.9021 High Similarity NPC187774
0.9021 High Similarity NPC280092
0.9021 High Similarity NPC472712
0.9021 High Similarity NPC472713
0.9021 High Similarity NPC45257
0.9021 High Similarity NPC473046
0.9021 High Similarity NPC63879
0.9021 High Similarity NPC179521
0.9021 High Similarity NPC15659
0.9021 High Similarity NPC12641
0.9021 High Similarity NPC118385
0.9021 High Similarity NPC304894
0.9021 High Similarity NPC93323
0.9014 High Similarity NPC476356
0.9007 High Similarity NPC27495
0.9007 High Similarity NPC177868
0.9007 High Similarity NPC262189
0.9007 High Similarity NPC22317
0.9 High Similarity NPC477938
0.8993 High Similarity NPC94750
0.8993 High Similarity NPC121812
0.8993 High Similarity NPC112939
0.8993 High Similarity NPC474206
0.8993 High Similarity NPC61946
0.8993 High Similarity NPC260898
0.8993 High Similarity NPC112246
0.8993 High Similarity NPC47398
0.8993 High Similarity NPC234333
0.8993 High Similarity NPC470356
0.8986 High Similarity NPC475840
0.8978 High Similarity NPC277804
0.8973 High Similarity NPC211561
0.8971 High Similarity NPC285339
0.8971 High Similarity NPC190629
0.8971 High Similarity NPC273295
0.8971 High Similarity NPC3439
0.8971 High Similarity NPC210623
0.8971 High Similarity NPC218856
0.8971 High Similarity NPC226788
0.8971 High Similarity NPC202582
0.8971 High Similarity NPC476968
0.8971 High Similarity NPC475875
0.8971 High Similarity NPC470258
0.8971 High Similarity NPC170844
0.8971 High Similarity NPC222004
0.8958 High Similarity NPC18979
0.8951 High Similarity NPC102044
0.8951 High Similarity NPC255566
0.8951 High Similarity NPC298317
0.8951 High Similarity NPC185071
0.8951 High Similarity NPC477898
0.8951 High Similarity NPC470950
0.8951 High Similarity NPC12728
0.8951 High Similarity NPC47633
0.8951 High Similarity NPC163508
0.8951 High Similarity NPC173203
0.8951 High Similarity NPC469630
0.8951 High Similarity NPC185307
0.8951 High Similarity NPC85264
0.8936 High Similarity NPC25966
0.8936 High Similarity NPC260741
0.8936 High Similarity NPC245207
0.8936 High Similarity NPC471388
0.8936 High Similarity NPC127218
0.8936 High Similarity NPC70682
0.8936 High Similarity NPC319647
0.8929 High Similarity NPC302701
0.8929 High Similarity NPC29799
0.8929 High Similarity NPC474639
0.8929 High Similarity NPC477939
0.8929 High Similarity NPC209985
0.8929 High Similarity NPC230734
0.8929 High Similarity NPC177160
0.8929 High Similarity NPC54743
0.8929 High Similarity NPC472336
0.8929 High Similarity NPC156502
0.8929 High Similarity NPC263367
0.8929 High Similarity NPC269091

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC114119 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8971 High Similarity NPD3027 Phase 3
0.8777 High Similarity NPD1613 Approved
0.8777 High Similarity NPD1612 Clinical (unspecified phase)
0.8489 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.8417 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.8357 Intermediate Similarity NPD4908 Phase 1
0.8333 Intermediate Similarity NPD6234 Discontinued
0.8239 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.8205 Intermediate Similarity NPD4966 Approved
0.8205 Intermediate Similarity NPD4967 Phase 2
0.8205 Intermediate Similarity NPD4965 Approved
0.8199 Intermediate Similarity NPD7228 Approved
0.8113 Intermediate Similarity NPD7199 Phase 2
0.8013 Intermediate Similarity NPD37 Approved
0.7986 Intermediate Similarity NPD1610 Phase 2
0.7963 Intermediate Similarity NPD6166 Phase 2
0.7963 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.7963 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.7902 Intermediate Similarity NPD2861 Phase 2
0.7901 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7898 Intermediate Similarity NPD1934 Approved
0.7877 Intermediate Similarity NPD3620 Phase 2
0.7877 Intermediate Similarity NPD3619 Clinical (unspecified phase)
0.7862 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7758 Intermediate Similarity NPD3818 Discontinued
0.7756 Intermediate Similarity NPD1653 Approved
0.7746 Intermediate Similarity NPD2983 Phase 2
0.7746 Intermediate Similarity NPD2982 Phase 2
0.774 Intermediate Similarity NPD6410 Clinical (unspecified phase)
0.7736 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.7721 Intermediate Similarity NPD5283 Phase 1
0.7703 Intermediate Similarity NPD5735 Approved
0.7698 Intermediate Similarity NPD1548 Phase 1
0.7697 Intermediate Similarity NPD6674 Discontinued
0.7688 Intermediate Similarity NPD6374 Clinical (unspecified phase)
0.7679 Intermediate Similarity NPD7240 Approved
0.7676 Intermediate Similarity NPD2981 Phase 2
0.7665 Intermediate Similarity NPD7074 Phase 3
0.7655 Intermediate Similarity NPD3018 Phase 2
0.764 Intermediate Similarity NPD3882 Suspended
0.7625 Intermediate Similarity NPD2801 Approved
0.7622 Intermediate Similarity NPD4749 Approved
0.7609 Intermediate Similarity NPD7157 Approved
0.7605 Intermediate Similarity NPD7054 Approved
0.7595 Intermediate Similarity NPD6055 Clinical (unspecified phase)
0.7574 Intermediate Similarity NPD228 Approved
0.7566 Intermediate Similarity NPD7266 Discontinued
0.756 Intermediate Similarity NPD7472 Approved
0.7551 Intermediate Similarity NPD4625 Phase 3
0.7518 Intermediate Similarity NPD7843 Approved
0.75 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD5844 Phase 1
0.7483 Intermediate Similarity NPD3705 Approved
0.7468 Intermediate Similarity NPD5698 Clinical (unspecified phase)
0.7442 Intermediate Similarity NPD7090 Clinical (unspecified phase)
0.7434 Intermediate Similarity NPD5588 Approved
0.7426 Intermediate Similarity NPD3022 Approved
0.7426 Intermediate Similarity NPD3021 Approved
0.7412 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.74 Intermediate Similarity NPD4060 Phase 1
0.74 Intermediate Similarity NPD1558 Phase 1
0.7399 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7394 Intermediate Similarity NPD5494 Approved
0.7389 Intermediate Similarity NPD1511 Approved
0.7381 Intermediate Similarity NPD7473 Discontinued
0.7379 Intermediate Similarity NPD4379 Clinical (unspecified phase)
0.7378 Intermediate Similarity NPD7975 Clinical (unspecified phase)
0.7372 Intermediate Similarity NPD5307 Clinical (unspecified phase)
0.7368 Intermediate Similarity NPD4537 Clinical (unspecified phase)
0.7368 Intermediate Similarity NPD4538 Approved
0.7368 Intermediate Similarity NPD7251 Discontinued
0.7368 Intermediate Similarity NPD4536 Approved
0.7363 Intermediate Similarity NPD7680 Approved
0.7362 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.7362 Intermediate Similarity NPD3817 Phase 2
0.7358 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7353 Intermediate Similarity NPD2684 Approved
0.7347 Intermediate Similarity NPD6917 Clinical (unspecified phase)
0.7347 Intermediate Similarity NPD6584 Phase 3
0.7343 Intermediate Similarity NPD6516 Phase 2
0.7343 Intermediate Similarity NPD5846 Approved
0.7342 Intermediate Similarity NPD7447 Phase 1
0.7333 Intermediate Similarity NPD7237 Clinical (unspecified phase)
0.7329 Intermediate Similarity NPD8651 Approved
0.7329 Intermediate Similarity NPD4675 Approved
0.7329 Intermediate Similarity NPD4678 Approved
0.7326 Intermediate Similarity NPD7808 Phase 3
0.7325 Intermediate Similarity NPD5058 Phase 3
0.7315 Intermediate Similarity NPD7095 Approved
0.731 Intermediate Similarity NPD6797 Phase 2
0.7308 Intermediate Similarity NPD6331 Phase 2
0.7308 Intermediate Similarity NPD7466 Approved
0.7305 Intermediate Similarity NPD6232 Discontinued
0.7296 Intermediate Similarity NPD1512 Approved
0.7278 Intermediate Similarity NPD7213 Phase 3
0.7278 Intermediate Similarity NPD7212 Phase 2
0.7273 Intermediate Similarity NPD1357 Approved
0.7267 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7267 Intermediate Similarity NPD4005 Discontinued
0.7267 Intermediate Similarity NPD6559 Discontinued
0.7261 Intermediate Similarity NPD6190 Approved
0.726 Intermediate Similarity NPD5327 Phase 3
0.7246 Intermediate Similarity NPD8127 Discontinued
0.7244 Intermediate Similarity NPD4237 Approved
0.7244 Intermediate Similarity NPD4236 Phase 3
0.7241 Intermediate Similarity NPD1091 Approved
0.7241 Intermediate Similarity NPD8054 Approved
0.7241 Intermediate Similarity NPD8053 Approved
0.7237 Intermediate Similarity NPD6355 Discontinued
0.7233 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7226 Intermediate Similarity NPD5762 Approved
0.7226 Intermediate Similarity NPD5763 Approved
0.7225 Intermediate Similarity NPD7549 Discontinued
0.7225 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7222 Intermediate Similarity NPD4380 Phase 2
0.7219 Intermediate Similarity NPD6233 Phase 2
0.7216 Intermediate Similarity NPD7906 Approved
0.7215 Intermediate Similarity NPD7124 Phase 2
0.7208 Intermediate Similarity NPD5960 Phase 3
0.7202 Intermediate Similarity NPD7229 Phase 3
0.7197 Intermediate Similarity NPD3892 Phase 2
0.7197 Intermediate Similarity NPD4109 Clinical (unspecified phase)
0.7197 Intermediate Similarity NPD4110 Phase 3
0.7195 Intermediate Similarity NPD1465 Phase 2
0.719 Intermediate Similarity NPD6653 Approved
0.719 Intermediate Similarity NPD6353 Approved
0.7171 Intermediate Similarity NPD4140 Approved
0.7171 Intermediate Similarity NPD5837 Clinical (unspecified phase)
0.7169 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.7169 Intermediate Similarity NPD7075 Discontinued
0.7162 Intermediate Similarity NPD3094 Phase 2
0.7161 Intermediate Similarity NPD6099 Approved
0.7161 Intermediate Similarity NPD2161 Phase 2
0.7161 Intermediate Similarity NPD6100 Approved
0.7159 Intermediate Similarity NPD4663 Approved
0.7152 Intermediate Similarity NPD6798 Discontinued
0.7143 Intermediate Similarity NPD6583 Phase 3
0.7143 Intermediate Similarity NPD6582 Phase 2
0.7134 Intermediate Similarity NPD3060 Approved
0.7134 Intermediate Similarity NPD5177 Phase 3
0.7134 Intermediate Similarity NPD1652 Phase 2
0.7124 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.7124 Intermediate Similarity NPD5124 Phase 1
0.7118 Intermediate Similarity NPD2489 Approved
0.7118 Intermediate Similarity NPD27 Approved
0.7115 Intermediate Similarity NPD2029 Clinical (unspecified phase)
0.7115 Intermediate Similarity NPD1375 Discontinued
0.7115 Intermediate Similarity NPD3540 Phase 1
0.7113 Intermediate Similarity NPD6671 Approved
0.7101 Intermediate Similarity NPD3051 Approved
0.7091 Intermediate Similarity NPD6818 Clinical (unspecified phase)
0.7091 Intermediate Similarity NPD2977 Approved
0.7091 Intermediate Similarity NPD5772 Approved
0.7091 Intermediate Similarity NPD2978 Approved
0.7091 Intermediate Similarity NPD5773 Approved
0.7091 Intermediate Similarity NPD8455 Phase 2
0.7089 Intermediate Similarity NPD4628 Phase 3
0.7086 Intermediate Similarity NPD7312 Approved
0.7086 Intermediate Similarity NPD7311 Approved
0.7086 Intermediate Similarity NPD7313 Approved
0.7086 Intermediate Similarity NPD4578 Approved
0.7086 Intermediate Similarity NPD4577 Approved
0.7086 Intermediate Similarity NPD7310 Approved
0.7081 Intermediate Similarity NPD52 Approved
0.7081 Intermediate Similarity NPD7527 Clinical (unspecified phase)
0.7081 Intermediate Similarity NPD7526 Approved
0.707 Intermediate Similarity NPD7037 Approved
0.7069 Intermediate Similarity NPD7685 Pre-registration
0.7063 Intermediate Similarity NPD4357 Discontinued
0.7059 Intermediate Similarity NPD2969 Approved
0.7059 Intermediate Similarity NPD2970 Approved
0.7059 Intermediate Similarity NPD2238 Phase 2
0.7055 Intermediate Similarity NPD7261 Clinical (unspecified phase)
0.7051 Intermediate Similarity NPD3539 Phase 1
0.7048 Intermediate Similarity NPD2563 Approved
0.7048 Intermediate Similarity NPD2560 Approved
0.7045 Intermediate Similarity NPD7309 Approved
0.7044 Intermediate Similarity NPD2677 Approved
0.7041 Intermediate Similarity NPD6959 Discontinued
0.7032 Intermediate Similarity NPD7097 Phase 1
0.7032 Intermediate Similarity NPD6111 Discontinued
0.7029 Intermediate Similarity NPD290 Approved
0.7027 Intermediate Similarity NPD3600 Clinical (unspecified phase)
0.7025 Intermediate Similarity NPD4162 Approved
0.702 Intermediate Similarity NPD5752 Clinical (unspecified phase)
0.7019 Intermediate Similarity NPD4123 Phase 3
0.7019 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.7013 Intermediate Similarity NPD3657 Discovery
0.7007 Intermediate Similarity NPD3092 Approved
0.7007 Intermediate Similarity NPD422 Phase 1
0.7006 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.7006 Intermediate Similarity NPD7768 Phase 2
0.7006 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.7 Intermediate Similarity NPD6071 Discontinued
0.6994 Remote Similarity NPD7804 Clinical (unspecified phase)
0.6988 Remote Similarity NPD7819 Suspended
0.6988 Remote Similarity NPD7096 Clinical (unspecified phase)
0.6987 Remote Similarity NPD6029 Clinical (unspecified phase)
0.6987 Remote Similarity NPD6028 Clinical (unspecified phase)
0.6981 Remote Similarity NPD6658 Clinical (unspecified phase)

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data